Nose-to Brain Delivery of Resveratrol, a Non-Invasive Method for the Treatment of Cerebral Ischemia
Cerebral ischemia represents a particular condition among neurological diseases due to its high frequency, high associated mortality, and the permanent disability in patients that survive it. Numerous studies in animal models have demonstrated the protective properties of resveratrol against cerebra...
Main Authors: | Iván Alquisiras-Burgos, Irma Gabriela González-Herrera, Sergio Alcalá-Alcalá, Penélope Aguilera |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-01-01
|
Series: | Drugs and Drug Candidates |
Subjects: | |
Online Access: | https://www.mdpi.com/2813-2998/3/1/7 |
Similar Items
-
Applications of resveratrol in the treatment of gastrointestinal cancer
by: Mohammad Roshani, et al.
Published: (2022-09-01) -
Resveratrol-Loaded Nanoemulsions: In Vitro Activity on Human T24 Bladder Cancer Cells
by: Federica Rinaldi, et al.
Published: (2021-06-01) -
Resveratrol Prevents GLUT3 Up-Regulation Induced by Middle Cerebral Artery Occlusion
by: Germán Fernando Gutiérrez Aguilar, et al.
Published: (2020-09-01) -
New Strategies for Stroke Therapy: Nanoencapsulated Neuroglobin
by: Santos Blanco, et al.
Published: (2022-08-01) -
Anti-CHAC1 exosomes for nose-to-brain delivery of miR-760-3p in cerebral ischemia/reperfusion injury mice inhibiting neuron ferroptosis
by: Yong Wang, et al.
Published: (2023-03-01)